Related Experiment Videos
Circulatory activity of dopamine-dipeptide compounds
1Institute of Drug Research, Academy of Sciences of the GDR, Berlin-Friedrichsfelde.
Biomedica Biochimica Acta
|January 1, 1988
Summary
Newly synthesized dopamine-dipeptide compounds show protective effects against hemorrhagic shock in rats. These compounds, cleaved by dipeptidyl peptidase IV, demonstrated vasodilation and increased survival times, similar to dopamine.
Area of Science:
- Pharmacology
- Biochemistry
- Physiology
Background:
- Dopamine plays a crucial role in cardiovascular regulation.
- Dipeptidyl peptidase IV (DPP-IV) is an enzyme involved in peptide metabolism.
- Novel dopamine-dipeptide compounds offer potential therapeutic avenues.
Purpose of the Study:
- To investigate the protective activity of three novel dopamine-dipeptide compounds against hemorrhagic shock.
- To evaluate the vasodilatory and blood pressure-modulating effects of these compounds.
- To compare their efficacy with dopamine.
Main Methods:
- Synthesis of Gly-Pro-dopamide, Lys-Pro-dopamide, and Z-Lys-Pro-dopamide.
- Assessment of protective activity in a rat model of hemorrhagic shock.
- Evaluation of vasodilation in isolated perfused rat kidneys.
- Measurement of blood pressure changes in rats.
Main Results:
- All three compounds significantly increased survival times in rats subjected to hemorrhagic shock.
- Compounds induced vasodilation via dopaminergic receptors in isolated rat kidneys.
- Gly-Pro-dopamide showed prolonged blood pressure effects compared to dopamine.
- Lys-Pro-dopamide and Z-Lys-Pro-dopamide exhibited similar blood pressure effects to dopamine.
Conclusions:
- The synthesized dopamine-dipeptide compounds possess protective properties against hemorrhagic shock.
- These compounds exhibit vasodilatory activity mediated by dopaminergic receptors.
- They represent promising candidates for further investigation in cardiovascular research and treatment.